416 ‒ The science of mitochondria: their role in health, aging, disease, and much more
Peter Attia MD
Mitochondria beyond ATP 0:00
Mitochondria are first treated as the cell’s powerhouse because they make ATP, the energy source that helps muscles and neurons work. But they also make the building blocks for new lipids, DNA, RNA, and proteins through the TCA cycle, or Krebs cycle. Their role depends on the cell. A hepatocyte may need more raw material for making things, while a muscle cell may need more ATP.
Signals, leak, and antioxidants 6:31
Mitochondria also send signals to the rest of the cell. Their electron transport chain can leak electrons, making superoxide and then H2O2, or hydrogen peroxide. That can be useful in small amounts, because it helps control proteins and cell behavior, but too much can drive damage and ferroptosis, a form of cell death. Antioxidant defenses such as catalase, peroxiredoxins, vitamin E, selenium-linked proteins like GPX4, and vitamin C help keep this in check.
Redox and metabolites 17:01
Vitamin C and selenium matter, but too much antioxidant can interfere with normal biology. The discussion shifts to three mitochondrial signals: hydrogen peroxide for immune function and cell differentiation, alpha ketoglutarate from the TCA cycle for acetylation and epigenetic control, and mitochondrial DNA or RNA as a danger signal when it leaks out.
Leakage and cell death 24:31
Mitochondrial DNA and RNA can activate inflammation through known receptors, though how they escape is still unclear. A low leak over years may help explain inflammaging, while cytochrome C release is the classic apoptosis signal. ATP still matters most, but cells can survive on glycolysis for months and still fail in function.
Mitochondria and cell survival 33:02
When mitochondria stop making enough ATP, AMPK turns on and tells mTOR to shut down anabolic work. The cell is then told to live on glycolysis. That can let a cell survive even while it is not fully functional. The speaker says this is a new way to think about mitochondrial signals, not just ATP, because those signals may be changed in disease.
Testing mitochondrial capacity 34:00
There is no simple noninvasive test. Metabolomics can show TCA cycle metabolites, and isolated mitochondria can be pushed with different fuels and ADP, but those tests do not reveal everything. The preferred field test is exercise with lactate kept below 2 mmol. As long as lactate stays low, you are near mitochondrial capacity; once it rises, glycolysis takes over.
Aging and mitochondrial harm 48:31
Mitochondrial dysfunction may be enough to make a cell fail, but that does not prove it drives normal aging in healthy people. The point is tested by pushing mitochondria past a threshold in mice. Nuclear DNA mutations produce aging-like changes more readily than mitochondrial DNA mutations do. With mitochondrial DNA, you often need about ten times the usual mutation load before the animal starts to degenerate, and even then it does not always look like ordinary aging.
Metformin acts in the gut 55:00
Metformin is then used as a case study. It is absorbed first in the gut, where its level is highest, then carried to the liver and cleared. It needs transporters to enter cells. The discussion turns to evidence that metformin mainly acts by inhibiting mitochondrial complex one, which shifts cells toward more glucose use. In mouse work, a yeast bypass protein called NDI1 blocks those effects and keeps gut glucose uptake and blood citrulline from dropping.
Metformin and the gut 1:05:31
Metformin may affect exercise and health through the gut as much as through the liver. The speakers discuss lowered B12, possible changes in citrulline, and a positive shift in the gut microbes. They also note that intravenous metformin goes more to the liver, while delayed release stays in the gut longer. That makes a circulating effect, rather than a direct muscle effect, seem more likely.
Glucose spikes and cancer 1:08:01
Metformin lowers the after-meal glucose spike when taken before food, and that is a strong reason to use it in people with prediabetes or marked insulin resistance. The discussion then turns to cancer. Mouse work suggests metformin can shrink tumors by inhibiting mitochondrial complex one, but the human trial record is mixed. The possible reason is tumor transport: some cancers may not take up metformin well, so a tumor may need the right transporter before the drug can work.
Metformin entry and target 1:21:00
Metformin still raises a basic question: how it gets into mitochondria. The speaker says the cell entry part is known through organic cation transporters one, two, or three, but the step from the cytoplasm into the inner matrix is still not figured out. New cryo work has mapped metformin binding on complex one, and that supports complex one as the main target. The point is tested further with NDI1, which can stand in for complex one and check whether that inhibition is really needed.
Uses beyond glucose 1:24:30
The practical question is whether you should take it. In a normal person it lowers glucose, and that alone may be useful. If a tumor has the right transporter, metformin could block growth, lower oxygen use, and raise oxygen in the tumor, which may help radiotherapy and immunotherapy. The speaker then turns to inflammation. Pollution can push mitochondria in alveolar macrophages to make H2O2 and drive IL6, and metformin lowered that signal in mice and cell studies.
Heart drugs and testing 1:37:00
SGL2 inhibitors come up first. They make you pee out glucose, and the speaker says they seem to help a failing heart by changing metabolism rather than fixing an intrinsic mitochondrial defect. He also says he does not trust blood, breath, or other noninvasive tests that claim to measure mitochondrial function. They may track steady-state metabolites, but that does not show flux, so he doubts they can give a reliable answer.
Cancer and supplements 1:41:01
He then turns to cancer and the Warburg effect. Cancer cells often make lactate even with oxygen present, but he says this usually does not mean their electron transport chain is broken. Most cancers still have intact mitochondria and use them to make energy and growth materials. He closes by weighing urolithin, berberine, and alpha ketoglutarate. He sees some promise in urolithin and likes alpha ketoglutarate more, but he says berberine mainly acts like metformin.
Alpha ketoglutarate and NAD 1:53:00
Alpha ketoglutarate may help in narrow cases such as colitis and gut injury from 5FU, where it supports stem cells and gut health. That is different from calling it a general anti-aging drug. The same caution applies to citrulline, carnitine, CoQ10, and NAD precursors. They may matter when a pathway is truly limited, but the evidence does not support routine use for healthy aging.
Drugs and oxygen 1:58:01
SS31 is an approved drug for a rare Bart syndrome mutation that affects cardiolipin and mitochondrial enzyme efficiency, but that does not make it a broad booster for everyone. Methylene blue may bypass parts of the electron chain, yet it has a narrow safety window and can cause serotonin toxicity. Hyperbaric oxygen is not advised outside wound care, while low oxygen has clear biology but is not a general longevity therapy.
Red light and metformin 2:09:01
A red light study showed a smaller glucose area under the curve during an oral glucose tolerance test after the back had been lit for a set time. It looked meaningful, though still less than the drop from modest exercise. The speaker wonders whether the effect comes from cytochrome oxidase in skin, which could push glucose use and maybe raise lactate. Metformin comes up as the more established drug, but its anti-inflammatory use is still uncertain.
AI-generated summary. It can be wrong or incomplete - check anything that matters against the original.

